Pfizer executive team & leadership
Pfizer's executive team includes 10 tracked leaders as of 2026-11-12, led by Albert Bourla (Chairman and Chief Executive Officer). The org chart, per-leader profiles and full leadership list are below.
Pfizer executive team overview
Pfizer has 10 tracked executives leading key functions including company strategy and operations, financial strategy, a key function, revenue and commercial operations (as of 2026-11-12). Pfizer Inc. is a biopharmaceutical company with global headquarters at 66 Hudson Boulevard East in New York City. Cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in 1849 in a red brick building in Brooklyn, and the present company was incorporated in Delaware on June 2, 1942. Its common stock trades on the New York Stock Exchange under the ticker PFE. Pfizer discovers, develops, manufactures and sells medicines and vaccines across oncology, internal medicine, inflammation and immunology, and vaccines, and manages its commercial operations through three operating segments: Biopharma, PC1 and Pfizer Ignite. It reported revenues of 62.6 billion dollars for 2025 and employed approximately 75,000 people worldwide at year end. Pfizer Global Supply runs 36 manufacturing plants, including in Belgium, Germany, India, Ireland, Italy, Japan, Singapore and the United States. Albert Bourla has been chief executive officer since January 2019 and chairman since January 2020. The company acquired Seagen in December 2023 and Metsera in November 2025.
Pfizer executive team org chart
Albert BourlaChairman and Chief Executive Officer- CGCecile GueganChief Financial Officer and Executive Vice President
- CBChris BoshoffChief Scientific Officer and President, Research & Development
- AMAamir MalikChief U.S. Commercial Officer
- ADAlexandre de GermayChief International Commercial Officer
- DLDoug LanklerChief Legal Officer
- MMMike McDermottChief Global Supply and Quality Officer
- PSPayal SahniChief People Experience Officer
- DHDennis HancockChief Information Officer
- LHLindsay HavernHead of Strategy, Executive Operations, Counsel to the CEO
Get this data with Derrick Find a company's people
Employees by management level
| Name | Profiles | Share |
|---|---|---|
| Executive Leadership Team | 10 | <0.1% |
| Senior vice presidents and vice presidents | 900 | 1.2% |
| Directors and senior managers | 9,000 | 12% |
| Managers and team leads | 16,000 | 21% |
| Individual contributors | 49,090 | 65% |
Get this data with Derrick Find a company's people
Leadership team
| Leader | Location | Profile | |
|---|---|---|---|
AB Albert BourlaChairman and Chief Executive Officer | ••••@pfizer.com | Profile → | |
| CGCecile GueganChief Financial Officer and Executive Vice President | ••••@pfizer.com | Profile → | |
| CBChris BoshoffChief Scientific Officer and President, Research & Development | ••••@pfizer.com | Profile → | |
| AMAamir MalikChief U.S. Commercial Officer | ••••@pfizer.com | Profile → | |
| ADAlexandre de GermayChief International Commercial Officer | ••••@pfizer.com | Profile → | |
| DLDoug LanklerChief Legal Officer | ••••@pfizer.com | Profile → | |
| MMMike McDermottChief Global Supply and Quality Officer | ••••@pfizer.com | Profile → | |
| PSPayal SahniChief People Experience Officer | ••••@pfizer.com | Profile → | |
| DHDennis HancockChief Information Officer | ••••@pfizer.com | Profile → | |
| LHLindsay HavernHead of Strategy, Executive Operations, Counsel to the CEO | ••••@pfizer.com | Profile → |
Get this data with Derrick Find a company's people
Find verified emails for the 10 leaders listed here and anyone else at Pfizer in the Derrick web app (5 credits per email found), or track Pfizer with Signal to be alerted when its leaders change jobs, it raises funds or starts hiring (Standard plan and up).
Pfizer executive team roles
Albert Bourla · full profile →
Chairman and Chief Executive Officer
Albert Bourla has been chief executive officer of Pfizer since January 2019 and chairman of the board since January 2020. Born in Thessaloniki, Greece, he is a doctor of veterinary medicine and spent more than 30 years at Pfizer, holding senior positions in five countries. He was chief operating officer in 2018 and before that group president of Pfizer Innovative Health. As chief executive he divested non-science businesses, raised investment in research and development, and led the response to COVID-19 with a vaccine delivered in eight months. He oversaw the acquisitions of Seagen in oncology and Metsera in obesity. He chairs the Pfizer Foundation and co-chairs the Partnership for New York City.
Cecile Guegan · full profile →
Chief Financial Officer and Executive Vice President
Cecile Guegan became chief financial officer and executive vice president of Pfizer on November 1, 2026, after serving as interim chief financial officer from August 16, 2026, when Dave Denton left the company. She has more than 25 years of finance experience in the pharmaceutical industry. She joined Pfizer through the 2009 acquisition of Wyeth, where she had been chief financial officer of the Asia Pacific and EMEA and Canada businesses. At Pfizer she held finance leadership roles in oncology, research and development and the Global Biopharmaceuticals business, and worked on major transactions including Seagen. She oversees audit, treasury, investor relations, tax and insurance.
Chris Boshoff · full profile →
Chief Scientific Officer and President, Research & Development
Chris Boshoff has been chief scientific officer and president of research and development at Pfizer since January 2025. He leads research and development across oncology, internal medicine, inflammation and immunology, and vaccines, along with medical affairs, safety, regulatory and the business development organization. He was previously chief oncology officer, in charge of cancer drug discovery, clinical development and U.S. commercialization, with research hubs in La Jolla and Seattle. Before joining Pfizer he was the founding director of the University College London Cancer Institute. A medical oncologist by training, he has published more than 150 original articles and contributed to early discoveries on Kaposi's sarcoma-associated herpesvirus.
Aamir Malik · full profile →
Chief U.S. Commercial Officer
Aamir Malik is executive vice president and chief U.S. commercial officer of Pfizer, a role he has held since December 2023. He leads the U.S. commercial business, which covers primary and specialty care, oncology, the global chief marketing office, U.S. medical affairs, market access and patient services, and U.S. policy and government relations. He joined Pfizer in August 2021 as chief business innovation officer, responsible for strategy, business development and portfolio management. Before Pfizer he was managing partner of the United States operations of McKinsey & Company and co-led its global pharmaceuticals and medical products practice.
Alexandre de Germay · full profile →
Chief International Commercial Officer
Alexandre de Germay is chief international commercial officer and executive vice president of Pfizer. Since December 2023 he has led the International Commercial Division, which groups the commercial organizations in every market outside the United States. He returned to Pfizer in 2023 after an earlier career of more than 20 years at the company that ended as regional president of Asia Pacific. In between he ran the general medicines business at Sanofi from 2016 and was chief executive officer of Laboratoires Majorelle, a French specialty pharma company focused on women's health and urology, from 2021.
Doug Lankler · full profile →
Chief Legal Officer
Douglas M. Lankler is executive vice president and chief legal officer of Pfizer. He joined the company in 1999, has been part of its management team since 2009 and has led the legal division since 2013, first as general counsel and, since January 2025, as chief legal officer. He is responsible for the legal side of corporate governance, compliance, litigation, business development, research, labor and intellectual property. Earlier he was chief compliance and risk officer. He is a former Assistant United States Attorney for the Southern District of New York and received the Attorney General's Distinguished Service Award in 1999.
Mike McDermott · full profile →
Chief Global Supply and Quality Officer
Mike McDermott is chief global supply and quality officer and executive vice president of Pfizer. He leads internal and external manufacturing and the supply chain through Pfizer Global Supply, a network of 36 manufacturing sites and about 31,000 colleagues that works with more than 300 contract manufacturers and supplies more than 185 countries. He came to Pfizer by way of Wyeth, where he started in 1989 as a project engineer in Pearl River, New York, and later ran plants and operating units. He was named president of Pfizer Global Supply in 2018. He sits on the executive committee of the National Association of Manufacturers.
Payal Sahni · full profile →
Chief People Experience Officer
Payal Sahni is chief people experience officer and executive vice president of Pfizer, where she leads the colleague and workplace experience strategy for an organization of nearly 75,000 people. Her remit covers culture, talent acquisition, total rewards, learning and development, colleague communications, real estate planning and security. She directed the human resources work on the integrations of Seagen and Metsera and leads the company's AI fluency initiative. She joined Pfizer human resources in 1997 and was chief human resources officer from June 2020 before taking her current title in January 2022. She serves on the U.S. advisory council of the Tent Partnership for Refugees.
Dennis Hancock · full profile →
Chief Information Officer
Dennis Hancock is chief information officer and executive vice president of Pfizer, where he leads the enterprise digital, artificial intelligence and technology strategy. He has spent more than 30 years at the company, in roles across research and development and global commercial solutions. Before becoming chief information officer he was senior vice president of digital, leading enterprise product management and learning and development. In 2024 he founded Health Answers by Pfizer, a generative AI platform that answers consumer health and wellness questions. Earlier he was the first general manager of Pfizer's Digital Health business unit, where he set the company's AI strategy and led the enterprise analytics and data organization.
Lindsay Havern · full profile →
Head of Strategy, Executive Operations, Counsel to the CEO
Lindsay Havern is head of strategy and executive operations at Pfizer and counsel to the chairman and chief executive officer. She leads the strategy and consulting function, which aligns the company around its strategic priorities, and oversees corporate communications and global health investments. She was previously senior vice president and chief compliance and risk counsel, leading a team of more than 180 people responsible for regulatory quality assurance, compliance and risk management for oncology, research and development, medical and global supply. Before joining Pfizer she was a partner at the law firm DLA Piper, focused on litigation and compliance.